The recent lockdown in Shanghai, China, has had a serious impact on GE Healthcare's primary pharmaceutical manufacturing facility for iohexol (Omipaque, GE Healthcare) iodinated contrast media (ICM), ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback